Unresectable Melanoma

Showing 26 - 46 of 46

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +19 more
Aug 1, 2022

Unresectable Melanoma, Metastatic Melanoma Trial in Orlando, Louisville, New York (Lifileucel)

Available
  • Unresectable Melanoma
  • Metastatic Melanoma
  • Lifileucel
  • Orlando, Florida
  • +2 more
Jul 19, 2022

NSCLC Stage IV, Melanoma Stage IV, Unresectable Melanoma Trial in Montréal (Camu Camu Capsules (Camu Camu powder encapsulated

Recruiting
  • NSCLC Stage IV
  • +3 more
  • Camu Camu Capsules (Camu Camu powder encapsulated (500mg each) + ICI
  • Montréal, Quebec, Canada
    Centre hospitalier de l'Université de Montréal (CHUM)
Jul 18, 2022

Unresectable Melanoma, Metastatic Melanoma, Stage III Melanoma Trial in Boston (Sargramostim (GM-CSF), Pembrolizumab

Recruiting
  • Unresectable Melanoma
  • +3 more
  • Sargramostim (GM-CSF)
  • Pembrolizumab (anti-PD-1)
  • Boston, Massachusetts
  • +1 more
Jul 6, 2022

Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Brain
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +3 more
  • Ipilimumab
  • Nivolumab
  • Rochester, Minnesota
    Mayo Clinic in Rochester
May 6, 2022

Unresectable Melanoma Trial in Pittsburgh (Nivolumab, Duvelisib)

Recruiting
  • Unresectable Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Apr 19, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma Trial in United States

Active, not recruiting
  • Stage IIIC Cutaneous Melanoma AJCC v7
  • +2 more
  • Bevacizumab
  • Ipilimumab
  • Birmingham, Alabama
  • +488 more
Mar 19, 2022

Unresectable Melanoma, Metastatic Melanoma Trial in France, United States (Nivolumab, Ipilimumab, Placebo)

Completed
  • Unresectable Melanoma
  • Metastatic Melanoma
  • San Francisco, California
  • +20 more
Feb 16, 2022

Unresectable Melanoma, Metastatic Melanoma Trial in Poland, Spain (APX005M)

Active, not recruiting
  • Unresectable Melanoma
  • Metastatic Melanoma
  • Warsaw, Poland
  • +12 more
Mar 8, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +4 more
  • Dabrafenib Mesylate
  • +3 more
  • Philadelphia, Pennsylvania
    Perelman Center for Advanced Medicine
Dec 29, 2021

Melanoma, BRAF V600 Mutation, Unresectable Melanoma Trial in Rennes (Binimetinib Oral Tablet)

Active, not recruiting
  • Melanoma
  • +3 more
  • Binimetinib Oral Tablet
  • Rennes, France
    Biotrial
Nov 30, 2021

BRAF V600 Mutation, Unresectable Melanoma, Metastatic Melanoma Trial in Czechia, Italy, Spain (Encorafenib + Binimetinib)

Not yet recruiting
  • BRAF V600 Mutation
  • +3 more
  • Encorafenib + Binimetinib
  • Olomouc, Czechia
  • +5 more
Sep 14, 2021

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +38 more
  • Scottsdale, Arizona
  • +2 more
Aug 27, 2021

Melanoma Stage IV, Unresectable Melanoma, NSCLC Stage IV Trial in Ramat Gan (Fecal Microbial Transplantation by capsules)

Recruiting
  • Melanoma Stage IV
  • +2 more
  • Fecal Microbial Transplantation by capsules
  • Ramat Gan, Israel
    Sheba Medical Center
Aug 9, 2021

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +5 more
  • Dietary Intervention
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 22, 2021

Stage III Melanoma, Stage IV Melanoma, Unresectable Melanoma Trial in Chapel Hill (BRAF inhibitor dabrafenib and MEK inhibitor

Completed
  • Stage III Melanoma
  • +3 more
  • BRAF inhibitor dabrafenib and MEK inhibitor trametinib
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center, University of North Caro
Nov 3, 2020

Metastatic Melanoma, Mucosal Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (biological, other,

Completed
  • Metastatic Melanoma
  • +4 more
  • Bevacizumab
  • +4 more
  • San Francisco, California
  • +12 more
Jan 7, 2020

Stage III Melanoma, Stage IV Melanoma, Unresectable Melanoma Trial in Orange (Pazopanib and Paclitaxel)

Completed
  • Stage III Melanoma
  • +2 more
  • Pazopanib and Paclitaxel
  • Orange, California
    Chao Family Comprehensive Cancer Center
Aug 5, 2019

Unresectable Melanoma Trial in Durham (Ipilimumab)

Completed
  • Unresectable Melanoma
  • Durham, North Carolina
    Duke University Medical Center
Oct 26, 2018